An International Publisher for Academic and Scientific Journals
Author Login 
SAS Journal of Medicine | Volume-12 | Issue-11
Early-Onset Rett Syndrome Associated with a Nonsense Mutation in the MECP2 Gene (c.502C>T; p.R168X): A Case Report
O. Cherkaoui Rhazouani*, K. Dafir
Published: Nov. 20, 2026 | 12 9
Pages: 1214-1217
Downloads
Abstract
Introduction: Rett syndrome (RTT) is a severe X-linked neurodevelopmental disorder that primarily affects girls. In the majority of cases, it is caused by loss-of-function mutations in the *MECP2* (methyl-CpG-binding protein 2) gene. Early recognition remains a clinical challenge before the full onset of the regression phase. Case Report: We report the case of an 18-month-old female infant, born to non-consanguineous parents with an unremarkable perinatal history, who presented with psychomotor delay and balance issues that emerged following a period of normal development during the first year of life. Clinical examination revealed acquired microcephaly, convergent strabismus, reduced eye contact, unprovoked laughter, hand spasticity accompanied by stereotypic hand movements (placing hands in the mouth), and ataxia. A brain MRI was normal. Direct sequencing of the *MECP2* gene identified a heterozygous, recurrent nonsense mutation: c.502C>T (p.R168X) in exon 4. Early multidisciplinary care, involving neurology, cardiology, physical therapy, speech therapy, and psychosocial support, led to a notable improvement in the child’s motor and communication skills. Conclusion: This case highlights the importance of considering Rett syndrome in any girl who experiences psychomotor regression after the age of 6 to 12 months. Early molecular identification of the p.R168X mutation helps prevent a prolonged diagnostic odyssey, facilitates the implementation of targeted rehabilitation, and ensures appropriate genetic counseling.